Scarica l'app Stockscreener
0.291
0.34%
-0.001
Precedente Chiudi:
$0.292
Aprire:
$0.304
Volume 24 ore:
64,519
Relative Volume:
0.49
Capitalizzazione di mercato:
$3.88M
Reddito:
$72,100
Utile/perdita netta:
$-3.60M
Rapporto P/E:
-0.2445
EPS:
-1.19
Flusso di cassa netto:
$-3.37M
1 W Prestazione:
-4.84%
1M Prestazione:
-24.42%
6M Prestazione:
-58.48%
1 anno Prestazione:
-80.73%
Intervallo 1D:
$0.29
$0.304
Intervallo di 1 settimana:
$0.2828
$0.33
Portata 52W:
$0.2705
$1.56
Silo Pharma Inc Stock (SILO) Company Profile
Nome
Silo Pharma Inc
Settore
Industria
Telefono
(718) 400-9031
Indirizzo
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO vs SHMD, GOODO, PSNYW, DWLD, QQQE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
7.55 | 483.19M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.30 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.00 | 268.25M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
46.10 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
102.68 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Borsa (SILO) Ultime notizie
Can Silo Pharma Inc. deliver alphaPortfolio Update Report & Free Community Consensus Stock Picks - mfd.ru
Hedge Fund Moves: Should value investors consider Silo Pharma IncJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
Stock Analysis: Is Silo Pharma Inc a defensive stockTrade Entry Report & Fast Entry High Yield Tips - baoquankhu1.vn
Insider Sell: How does Silo Pharma Inc score in quality rankingsQuarterly Performance Summary & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Wrap: Is Allegion plc part of any ETFProfit Target & Technical Confirmation Trade Alerts - baoquankhu1.vn
VIX Spike: Is Silo Pharma Inc a strong growth stock2025 Analyst Calls & Fast Gaining Stock Reports - baoquankhu1.vn
ETF Watch: Should you avoid Opthea Limited Depositary Receipt stock right now2025 Earnings Impact & Long-Term Investment Growth Plans - baoquankhu1.vn
Silo Pharma Announces Closing of $5.75 Million Public Offering of Common Stock, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option - Psychedelic Alpha
Short Squeeze: Is IFBD stock risky to hold now2025 Biggest Moves & High Yield Equity Trading Tips - baoquankhu1.vn
Bearish Setup: Will Silo Pharma Inc face regulatory challengesJuly 2025 Short Interest & Fast Moving Trade Plans - baoquankhu1.vn
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% - MSN
Analysis Recap: Is Silo Pharma Inc stock forming a cup and handleQuarterly Trade Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Weekly Recap: Is Silo Pharma Inc stock a safe haven asset2025 Growth vs Value & Weekly Momentum Picks - moha.gov.vn
Can Silo Pharma Inc. stock sustain institutional interest2025 Macro Impact & Pattern Based Trade Signal System - Улправда
ETF Watch: Why Silo Pharma Inc. stock could be next big winnerBond Market & Fast Gain Stock Trading Tips - Улправда
Why Silo Pharma Inc. stock could be next big winner2025 Earnings Surprises & Weekly High Return Stock Opportunities - Улправда
How Silo Pharma Inc. stock reacts to job market dataJuly 2025 Momentum & Real-Time Volume Spike Alerts - ulpravda.ru
Is Silo Pharma Inc. stock a safe haven assetMarket Growth Summary & Daily Volume Surge Trade Alerts - Улправда
Why Silo Pharma Inc. stock could see breakout soon2025 Momentum Check & Safe Entry Trade Reports - Улправда
Silo Pharma Teams with Allucent for SPC-15 Trials - BioXconomy
What drives Soligenix Inc DOA0 stock priceMerger & Acquisition Updates & Buy Sell Timing Alerts - earlytimes.in
Sheppard Mullin Advised Vanterra Ventures, Silo Pharma, Celularity And Others In Recent Deals - Mondaq
Silo Pharma (NASDAQ:SILO) Stock Price Down 2.9% – Here’s Why - Defense World
Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials - Investing.com Nigeria
Silo Pharma Receives Extended Nasdaq Compliance Grace Period - The Globe and Mail
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 - GlobeNewswire
Silo Pharma receives extension from Nasdaq to regain minimum bid price compliance - Investing.com
Silo Pharma Received Notice of Noncompliance - TradingView — Track All Markets
How Silo Pharma Inc. stock responds to policy changesEconomic Indicators Overview & Small Entry Trading Portfolio - bollywoodhelpline.com
Is Silo Pharma Inc. stock a buy in volatile marketsQuarterly Risk Review & Low Risk Profit Maximizing Plans - Улправда
How Silo Pharma Inc. stock performs in rising dollar environmentJuly 2025 Macro Moves & Free Community Consensus Stock Picks - Улправда
Gains Report: Is Silo Pharma Inc. stock a buy in volatile markets2025 Trading Recap & AI Forecasted Entry and Exit Points - Улправда
Momentum Shift: How geopolitical tensions affect Silo Pharma Inc. stockRecession Risk & Real-Time Chart Pattern Alerts - Улправда
Can Silo Pharma Inc. stock resist market sell offs2025 Earnings Surprises & Daily Entry Point Alerts - Улправда
Why Silo Pharma Inc. stock remains resilientBuy Signal & High Accuracy Trade Signal Alerts - Улправда
Is Silo Pharma Inc. stock a safe investment in uncertain markets2025 Market Sentiment & Stepwise Trade Signal Guides - Улправда
VIX Spike: Is Silo Pharma Inc. stock a safe haven assetQuarterly Market Summary & High Win Rate Trade Tips - moha.gov.vn
Silo Pharma (SILO) CEO Eric Weisblum reports December insider share purchases - Stock Titan
Silo Pharma (NASDAQ:SILO) Stock Price Down 2.8% – What’s Next? - Defense World
How Silo Pharma Inc. stock performs during Fed tightening cycles2025 Top Decliners & Community Verified Trade Alerts - Newser
SILO Pharma (SILO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Silo Pharma Inc a good long term investmentContrarian Investment Ideas & Free Record-Breaking Gains - earlytimes.in
Silo Pharma CEO Weisblum buys $735 in company stock By Investing.com - Investing.com Australia
Silo Pharma CEO Weisblum buys $735 in company stock - Investing.com India
[Form 4] Silo Pharma, Inc. Insider Trading Activity - Stock Titan
Will earnings trigger a reversal in Silo Pharma Inc.Market Risk Report & Smart Investment Allocation Tips - newser.com
Silo Pharma Inc Azioni (SILO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):